Mizrahi, J., Senapedis, W., O'Donnell, C., Hodgson, J. G., Newman, J. V., Siecinski, S., Lin, C. (2025). First-in-human phase 1/2 study (MYCHELANGELO I) of first-in-class epigenomic controller OTX-2002 targeting MYC oncogene in patients with hepatocellular carcinoma (HCC) and other solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.606